tiprankstipranks
Satellos Bioscience (DE:0IT)
FRANKFURT:0IT
Germany Market
0IT
Satellos Bioscience
RESEARCH TOOLSreports

Satellos Bioscience (0IT) Income Statement

0 Followers

Satellos Bioscience Income Statement

Last quarter (Q2 2026), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Satellos Bioscience's net income was C$-12.09M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
$ -5.09KC$ -20.00KC$ -8.82MC$ -3.73MC$ -165.69K
Operating Expenses
$ 26.92MC$ 27.79MC$ 15.46MC$ 4.69MC$ 4.70M
Depreciation and Amortization
$ 5.09KC$ 20.00KC$ 7.00KC$ 337.00KC$ 165.69K
EBITDA
$ -26.92MC$ -28.08MC$ -15.71MC$ -8.09MC$ -4.69M
Operating Income
$ -26.92MC$ -27.81MC$ -15.46MC$ -8.43MC$ -6.65M
Other Income/Expenses
$ 1.79MC$ -291.00KC$ -426.00KC$ -2.89MC$ -8.86M
Pretax Income
$ -25.13MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Net Income
$ -25.31MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Per Share Metrics
Basic EPS
$ -1.73C$ -2.94C$ -2.21C$ -3.81C$ -7.73
Diluted EPS
$ -1.73C$ -2.94C$ -2.21C$ -3.81C$ -7.73
Weighted Average Shares Outstanding
 14.60M 9.56M 7.20M 2.97M 2.01M
Weighted Average Shares Outstanding (Diluted)
 14.60M 9.56M 7.20M 2.97M 2.01M

Satellos Bioscience Earnings and Revenue History